Brief: NeuroVive Pharmaceutical Q2 Pre-Tax Loss Narrows To SEK 20.8 Mln

Abliva AB

21/08/2019 07:43

Aug 21 (Reuters) - NeuroVive Pharmaceutical AB  NVP.ST :
    * INTERIM REPORT JANUARY - JUNE 2019
    * Q2 NET REVENUES: KSEK 85 (0)
    * Q2 PRE-TAX LOSS SEK 20.8 MILLION VERSUS LOSS SEK 25.5
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr9fFQgx 
Further company coverage:  NVP.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))